IN2015DN00833A - - Google Patents
Download PDFInfo
- Publication number
- IN2015DN00833A IN2015DN00833A IN833DEN2015A IN2015DN00833A IN 2015DN00833 A IN2015DN00833 A IN 2015DN00833A IN 833DEN2015 A IN833DEN2015 A IN 833DEN2015A IN 2015DN00833 A IN2015DN00833 A IN 2015DN00833A
- Authority
- IN
- India
- Prior art keywords
- pemetrexed
- crystalline form
- salt
- synthesis
- lysine salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000398A ITRM20120398A1 (it) | 2012-08-08 | 2012-08-08 | Procedimento di sintesi pemetrexed e suo sale di lisina. |
PCT/IB2013/056497 WO2014024164A1 (en) | 2012-08-08 | 2013-08-08 | Process for the preparation of pemetrexed and lysin salt thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2015DN00833A true IN2015DN00833A (es) | 2015-06-12 |
Family
ID=47018368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN833DEN2015 IN2015DN00833A (es) | 2012-08-08 | 2013-08-08 |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP2882753B1 (es) |
KR (1) | KR102288417B1 (es) |
CN (1) | CN104736540B (es) |
AU (1) | AU2013301156B2 (es) |
BR (1) | BR112015002429A8 (es) |
CY (1) | CY1118514T1 (es) |
DK (1) | DK2882753T3 (es) |
ES (1) | ES2607890T3 (es) |
HK (1) | HK1209426A1 (es) |
HR (1) | HRP20170011T1 (es) |
HU (1) | HUE032304T2 (es) |
IN (1) | IN2015DN00833A (es) |
IT (1) | ITRM20120398A1 (es) |
LT (1) | LT2882753T (es) |
MX (1) | MX362858B (es) |
PL (1) | PL2882753T3 (es) |
PT (1) | PT2882753T (es) |
RS (1) | RS55515B1 (es) |
RU (1) | RU2609006C2 (es) |
SI (1) | SI2882753T1 (es) |
SM (1) | SMT201600474B (es) |
TW (1) | TWI609017B (es) |
WO (1) | WO2014024164A1 (es) |
ZA (1) | ZA201501549B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107641124A (zh) * | 2016-07-22 | 2018-01-30 | 上海创诺制药有限公司 | 一种培美曲塞二酸新晶型及其制备方法 |
CN109836425B (zh) * | 2017-11-24 | 2023-01-24 | 江苏创诺制药有限公司 | 一种合成培美酸的制备工艺 |
CN110128427A (zh) * | 2018-02-09 | 2019-08-16 | 鲁南制药集团股份有限公司 | 培美曲塞缬氨酸盐 |
CN110128428A (zh) * | 2018-02-09 | 2019-08-16 | 鲁南制药集团股份有限公司 | 培美曲塞丙氨酸盐 |
CN110128426B (zh) * | 2018-02-09 | 2021-12-14 | 鲁南制药集团股份有限公司 | 培美曲塞谷氨酸盐 |
CN111333658A (zh) * | 2020-05-06 | 2020-06-26 | 贵州联科中贝制药科技有限公司 | 一种培美曲塞二钠水合物的制备方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990005128A1 (en) | 1988-10-31 | 1990-05-17 | Mitsui Toatsu Chemicals, Inc. | Process for preparing organic group-substituted sodium aluminum hydride |
KR0162654B1 (ko) | 1989-12-11 | 1998-11-16 | 알렌 제이. 시니스갤리 | N-(피롤로[2,3-d]피리미딘-3-일아크릴)-글루타민산 유도체 |
IL96531A (en) | 1989-12-11 | 1995-08-31 | Univ Princeton | History of Acid N- (Diomeric-H1-Pyrolo] D-2,3 [Pyrimidine-3-Ilacyl (-glutamic, preparation and pharmaceutical preparations containing them) |
US5416211A (en) * | 1992-09-25 | 1995-05-16 | Eli Lilly And Company | Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines |
IL107041A (en) * | 1992-09-25 | 2000-02-17 | Lilly Co Eli | Process for preparing omega(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo-6-¬2,3-d¾pyrimidin-5-YL)alkarylcarboxylic acids and N-(omega-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo¬2,3-d¾pyrimidin-5-YL)alk-aroyl-4-glutamic acids |
DE19725647A1 (de) | 1997-06-18 | 1998-12-24 | Basf Ag | Cyclopenta[I]phenanthren-Metallkomplex-Katalysatorsysteme |
ZA987550B (en) | 1997-09-26 | 2000-02-21 | Lilly Co Eli | Processes and intermediates useful to make antifolates. |
JP4846158B2 (ja) | 2000-02-25 | 2011-12-28 | イーライ リリー アンド カンパニー | N−[4−[2−(2−アミノ−4,7−ジヒドロ−4−オキソ−3H−ピロロ[2,3−d]ピリミジン−5−イル)エチル]ベンゾイル]−L−グルタミン酸の新規結晶形およびその製造方法 |
KR101101443B1 (ko) * | 2006-08-14 | 2012-01-03 | 시코르, 인크. | 페메트렉세드의 중간체의 제조 방법 |
EP1934226A2 (en) * | 2006-08-14 | 2008-06-25 | Sicor, Inc. | Highly pure pemetrexed diacid and processes for the preparation thereof |
CN101591247B (zh) * | 2008-05-30 | 2012-09-05 | 上海希迪制药有限公司 | 合成4-(4-甲酯基苯基)丁醛的方法 |
IT1401677B1 (it) * | 2010-07-22 | 2013-08-02 | Chemi Spa | Nuovo processo per la sintesi di pemetrexed sale disodico |
US9655898B2 (en) | 2010-07-28 | 2017-05-23 | Eagle Pharmaceuticals, Inc. | Pharmaceutical compositions containing pemetrexed having extended storage stability |
WO2012056285A1 (en) * | 2010-10-25 | 2012-05-03 | Fresenius Kabi Oncology Ltd. | An improved process for the preparation of pemetrexed |
-
2012
- 2012-08-08 IT IT000398A patent/ITRM20120398A1/it unknown
-
2013
- 2013-08-06 TW TW102128058A patent/TWI609017B/zh active
- 2013-08-08 EP EP13777144.0A patent/EP2882753B1/en active Active
- 2013-08-08 RU RU2015108042A patent/RU2609006C2/ru active
- 2013-08-08 WO PCT/IB2013/056497 patent/WO2014024164A1/en active Application Filing
- 2013-08-08 RS RS20161202A patent/RS55515B1/sr unknown
- 2013-08-08 MX MX2015001712A patent/MX362858B/es active IP Right Grant
- 2013-08-08 PT PT137771440T patent/PT2882753T/pt unknown
- 2013-08-08 DK DK13777144.0T patent/DK2882753T3/en active
- 2013-08-08 PL PL13777144T patent/PL2882753T3/pl unknown
- 2013-08-08 CN CN201380041935.8A patent/CN104736540B/zh active Active
- 2013-08-08 ES ES13777144.0T patent/ES2607890T3/es active Active
- 2013-08-08 AU AU2013301156A patent/AU2013301156B2/en active Active
- 2013-08-08 KR KR1020157005932A patent/KR102288417B1/ko active IP Right Grant
- 2013-08-08 IN IN833DEN2015 patent/IN2015DN00833A/en unknown
- 2013-08-08 BR BR112015002429A patent/BR112015002429A8/pt not_active Application Discontinuation
- 2013-08-08 LT LTEP13777144.0T patent/LT2882753T/lt unknown
- 2013-08-08 SI SI201330427A patent/SI2882753T1/sl unknown
- 2013-08-08 HU HUE13777144A patent/HUE032304T2/en unknown
-
2015
- 2015-03-06 ZA ZA2015/01549A patent/ZA201501549B/en unknown
- 2015-10-19 HK HK15110234.8A patent/HK1209426A1/zh unknown
-
2016
- 2016-12-28 SM SM201600474T patent/SMT201600474B/it unknown
- 2016-12-28 CY CY20161101351T patent/CY1118514T1/el unknown
-
2017
- 2017-01-05 HR HRP20170011TT patent/HRP20170011T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
RS55515B1 (sr) | 2017-05-31 |
MX362858B (es) | 2019-02-20 |
CY1118514T1 (el) | 2017-07-12 |
AU2013301156B2 (en) | 2017-08-31 |
ZA201501549B (en) | 2016-01-27 |
KR102288417B1 (ko) | 2021-08-11 |
EP2882753B1 (en) | 2016-10-05 |
HK1209426A1 (zh) | 2016-04-01 |
ES2607890T3 (es) | 2017-04-04 |
KR20150045458A (ko) | 2015-04-28 |
LT2882753T (lt) | 2016-12-12 |
BR112015002429A2 (pt) | 2017-07-04 |
RU2609006C2 (ru) | 2017-01-30 |
RU2015108042A (ru) | 2016-09-27 |
CN104736540A (zh) | 2015-06-24 |
TW201412741A (zh) | 2014-04-01 |
WO2014024164A1 (en) | 2014-02-13 |
SI2882753T1 (sl) | 2017-02-28 |
AU2013301156A1 (en) | 2015-02-05 |
ITRM20120398A1 (it) | 2014-02-09 |
DK2882753T3 (en) | 2017-01-16 |
HRP20170011T1 (hr) | 2017-03-10 |
SMT201600474B (it) | 2017-03-08 |
HUE032304T2 (en) | 2017-09-28 |
MX2015001712A (es) | 2015-08-14 |
CN104736540B (zh) | 2017-08-25 |
TWI609017B (zh) | 2017-12-21 |
PT2882753T (pt) | 2016-12-27 |
BR112015002429A8 (pt) | 2019-07-30 |
PL2882753T3 (pl) | 2017-04-28 |
EP2882753A1 (en) | 2015-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2015KN00262A (es) | ||
PL3409674T3 (pl) | Sposób wytwarzania kompozycji użytecznych do leczenia zaburzeń związanych z KIT | |
MD20150091A2 (ro) | Compuşi antivirali | |
IN2014MN02598A (es) | ||
ZA201206254B (en) | Novel salts for the manufacture of pharmaceutical compositions | |
IN2015DN00833A (es) | ||
MX349224B (es) | Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa. | |
EA029539B8 (ru) | Фармацевтическая композиция ситаглиптина | |
MX2014010433A (es) | Nueva forma cristalina de sulfato de sitagliptina. | |
MY166449A (en) | Pharmaceutical composition of rosuvastatin calcium | |
MX2014004196A (es) | Citramida de rasagilina. | |
NZ708371A (en) | Methods for treating pruritus | |
MX337721B (es) | Compuestos de heteroarilo como ligandos del receptor 5-ht4. | |
MY160902A (en) | Process for the preparation of the L-arginine salt of perindopril | |
IN2014DN06964A (es) | ||
MX2014002625A (es) | Nuevas composiciones para la produccion de poliamidas coladas. | |
MX339858B (es) | Compuestos novedosos como ligandos del receptor h3 de la histamina. | |
IN2014MN01671A (es) | ||
IN2013MU03070A (es) | ||
IN2015DN00085A (es) | ||
IN2015DN00950A (es) | ||
IN2014DN03245A (es) | ||
IN2014DN09451A (es) | ||
HK1211845A1 (en) | Processes for preparing toothpaste compositions | |
MX351789B (es) | Nueva composicion para la preparación de poliamidas de fundido.. |